© 2017 Stanningly Pharma

Tel: +44 (0) 115 912 4253  Email: info@stanningleypharma.co.uk

BioCity, Pennyfoot Street, Nottingham NG1 1GF

  • White Facebook Icon
  • White Twitter Icon
  • White Google+ Icon

Far-Infrared Therapy Unit

Fistula Care with Far-Infrared Therapy Unit

 

Clininical Benefits

  • Clinically proven to support fistula maturation and patency

  • Improves pain and steal syndrome

  • Improves haematoma clearance

  • Improves fistulaplasty reqirements

  • The only Far Infrared medical device for kidney patients, supported by published clinical trials, and used in the NHS for fistula care

Patient Experience

  • Pleasant warm sensation

  • Relieves post veno-puncture bruising

  • Reduces pain at fistula

  • Improves wound healing

Easy To Operate

  • 40 min self timer

  • Mobile between patients

  • Used for 40 mins, at least 3x per week whilst on or off dialysis

  • Available to patients or hospitals

  • Purchase or lease

  • Fully guaranteed for 2 years

Administration

 

  • Position the emitter 20-30cm above the fistula

  • The fistula should be exposed and not covered

  • Treatment should be given for 40 mins 3x/week.

  • The patient can be either on or off haemodialysis

  • Treatment should finish 30 mins before the end of the haemodialysis

Far-Infrared Therapy

 

  • Non invasive

  • Low risk

  • Low heat

  • Can be given on HD, in clinic or at home

  • Simple to administer

Fistula Care

Ordering

Product Far Infrared Therapy Unit

NHS list price (ex VAT) Available on request

Wholesalers Contact Stanningley Pharma on 0115 9124253 for more information

 For further information regarding products or purchasing please contact Stanningley Pharma: Info@stanningleypharma.co.uk or tel 0115 9124253